PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Matthew Kang, MD, FRCPC - Putting the Individual in ITP: Enhancing Patients Outcomes With TPO-RAs
Visit https://www.peervoice.com/BJA860 to view the entire programme with slides. After completing “Matthew Kang, MD, FRCPC - Putting the Individual in ITP: Enhancing Patients Outcomes With TPO-RAs”, participants will be able to: Review the clinical evidence with second-line medical therapies for the treatment of immune thrombocytopenia (ITP); Discuss the role of thrombopoietin-receptor agonists (TPO-RAs) in the medical management of ITP; and Formulate a patient-centered approach to tailor TPO-RA treatment selection in patients with ITP.